CVS HEALTH Corp (CVS)
CVS HEALTH Corp (CVS) from its SEC filings: 2025 revenue $402.1 billion (+8% vs the year before), net margin 0%, free cash flow $7.8 billion. Insider trades, recent filings and a price chart. Free.
| Exchange | NYSE |
| Industry | Retail-Drug Stores And Proprietary Stores |
| Revenue (2025) | $402.1 billion |
| Revenue growth | +8% |
| Net income | $1.8 billion |
| Net margin | 0.4% |
| Free cash flow | $7.8 billion |
| Diluted EPS | $1.39 |
| Latest quarter (Q2 2026 (calendar)) revenue vs a year earlier | +7% |
| Cash | $11.3 billion |
| Long-term debt | $63.5 billion |
| Share count, 1 year | +1% |
| Fundamentals check | Mixed fundamentals |
Source: SEC EDGAR company filings (XBRL), updated 2026-10-23. Education only, not financial advice.